VVOS
- Vivos Therapeutics, Inc.
()
Overview
Company Summary
Vivos Therapeutics, Inc. (VVOS) is a medical technology company focused on innovative solutions for the treatment of obstructive sleep apnea (OSA) and other breathing disorders. OSA is a common sleep disorder characterized by repeated pauses in breathing or shallow breathing during sleep, leading to disrupted rest and potential health complications.
Vivos Therapeutics primarily offers the Vivos System, a proprietary, non-invasive treatment approach for OSA. The Vivos System aims to help patients by addressing the root causes of airway obstruction, including anatomical deficiencies and soft tissue restrictions in the oral cavity and throat.
The treatment process involves a personalized oral appliance designed to gently reposition and expand the patient's jaws, which subsequently enlarges the airway. By improving the structural integrity of the upper airway and enhancing breathing patterns during sleep, the Vivos System aims to provide significant relief from the symptoms and health risks associated with sleep apnea.
Vivos Therapeutics operates through a network of specially trained and certified healthcare providers, including dentists and other medical professionals, who facilitate the diagnosis, treatment planning, and ongoing monitoring of patients using the Vivos System. The company's approach combines clinical expertise, advanced medical technology, and patient education to deliver personalized and effective treatment for individuals suffering from sleep apnea.
In summary, Vivos Therapeutics, Inc. is a medical technology company that focuses on providing innovative solutions for the treatment of obstructive sleep apnea. Through its proprietary Vivos System, the company aims to improve the quality of life for individuals with sleep apnea by addressing the underlying anatomical causes of airway obstruction.